Medicxi Ventures Management (Jersey) Ltd

Holdings History for Centessa Pharmaceuticals plc - Ordinary shares, nominal value 0.002 GBP per share (CNTA)

Symbol: CNTA on Nasdaq
Investment type: Equity / Ordinary shares, nominal value 0.002 GBP per share

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	60%	0%	$499,278,557	19,963,157	0		$25.01	Q4 2025
30 Sep 2025	65%	0%	$484,106,557	19,963,157	0		$24.25	Q3 2025
30 Jun 2025	61%	0%	$262,315,883	19,963,157	0		$13.14	Q2 2025
31 Mar 2025	66%	0%	$287,070,198	19,963,157	0		$14.38	Q1 2025
31 Dec 2024	63%	0%	$334,382,880	19,963,157	0		$16.75	Q4 2024
30 Sep 2024	60%	0%	$319,210,880	19,963,157	0		$15.99	Q3 2024
30 Jun 2024	54%	0%	$180,267,308	19,963,157	0		$9.03	Q2 2024
31 Mar 2024	50%	0%	$225,583,674	19,963,157	0		$11.30	Q1 2024
31 Dec 2023	54%	0%	$158,906,730	19,963,157	0		$7.96	Q4 2023
30 Sep 2023	41%	0%	$129,161,626	19,963,157	0		$6.47	Q3 2023
30 Jun 2023	35%	0%	$123,571,942	19,963,157	0		$6.19	Q2 2023
31 Mar 2023	33%	0%	$76,858,154	19,963,157	0		$3.85	Q1 2023
31 Dec 2022	26%	0%	$61,885,786	19,963,157	0		$3.10	Q4 2022
30 Sep 2022	33%	0%	$80,252,000	19,963,157	0		$4.02	Q3 2022
30 Jun 2022	40%	0%	$97,221,000	19,963,157	0		$4.87	Q2 2022
31 Mar 2022	49%	+4.5%	$179,070,000	19,963,157	+1,839,265	+10%	$8.97	Q1 2022
31 Dec 2021	51%	+0.56%	$204,075,000	18,123,892	+200,000	+1.1%	$11.26	Q4 2021
30 Sep 2021	65%	0%	$299,329,000	17,923,892	0		$16.70	Q3 2021
30 Jun 2021	71%	+71%	$398,090,000	17,923,892	+17,923,892	NEW	$22.21	Q2 2021

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.